SCOPUS 정보 검색 플랫폼

Volumn 46, Issue 5, 2000, Pages 827-830

In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia

(5) Joly Guillou, M L a Wolff, M b Farinotti, R c Bryskier, A e Carbon, C d

a HÔPITAL LOUIS MOURIER (France)

b Clinique de de Réanimation des Maladies Infectieuses (France)

c Service de Pharmacie Clinique (France)

d BICHAT HOSPITAL (France)

e SANOFI (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; DICHLOROMETHANE; IMIPENEM; LEVOFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL PNEUMONIA; BACTERICIDAL ACTIVITY; CASE REPORT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HUMAN; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; SURVIVAL;

EID: 0033745914 PISSN: 03057453 EISSN: None Source Type: Journal
DOI: 10.1093/jac/46.5.827 Document Type: Article

Times cited : (33)

References (9)

1
- 0029808374
- Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: Assessment by quantitative culture of samples obtained by a protected specimen brush
- (1996) Clinical Infectious Diseases , vol.23 , pp. 538-542
- Fagon, J.Y.¹ Chastre, J.² Domart, Y.³ Trouillet, J.L.⁴ Gibert, C.⁵

2
- 0031039715
- Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem
- (1997) Antimicrobial Agents and Chemotherapy , vol.41 , pp. 345-351
- Joly-Guillou, M.L.¹ Wolff, M.² Pocidalo, J.J.³ Walker, F.⁴ Carbon, C.⁵

3
- 0019412616
- Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma
- (1981) Clinical Chemotherapy , vol.27 , pp. 1190-1197
- Jolley, M.E.¹ Stroupe, S.D.² Wang, C.H.³ Panas, H.N.⁴ Keegan, C.L.⁵ Schmidt, R.L.⁶

4
- 0016844804
- Clinical pharmaco-kinetics
- (1975) New England Journal of Medicine , vol.293 , pp. 964-970
- Greenblatt, D.J.¹ Koch-Weser, J.²

5
- 0031952586
- Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
- (1998) Clinical Infectious Disease , vol.26 , pp. 1-12
- Craig, W.A.¹

6
- 0031848357
- Pharmacodynamic activities of ciprofloxacin and sparfloxacin in a murine pneumococcal pneumonia model: Relevance for drug efficacy
- (1998) Journal of Pharmacology and Experimental Therapeutics , vol.286 , pp. 29-35
- Bedos, J.P.¹ Azoulay-Dupuis, E.² Moine, P.³ Muffat-Joly, M.⁴ Veber, B.⁵ Pocidalo, J.J.⁶

7
- 0027457842
- Pharamacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis
- (1993) Antimicrobial Agents and Chemotherapy , vol.37 , pp. 483-490
- Drusano, G.L.¹ Johnson, D.² Rosen, M.³ Standiford, M.C.⁴

8
- 0027161344
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
- (1993) Antimicrobial Agents and Chemotherapy , vol.37 , pp. 1073-1081
- Forrest, A.¹ Nix, D.E.² Ballow, C.H.³ Goss, T.F.⁴ Birmingham, M.C.⁵ Schentag, J.J.⁶

9
- 0029781290
- Adaptive resistance to tobramycin in Pseudomonas aeruginosa lung infection in cystic fibrosis
- (1996) Journal of Antimicrobial Chemotherapy , vol.37 , pp. 1155-1164
- Barclay, M.L.¹ Begg, E.J.² Chambers, S.T.³ Thornley, P.E.⁴ Pattemore, P.K.⁵ Grinwood, K.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.